ArticleNature methods2026
Compressing the collective knowledge of ESM into a single protein language model.
Article in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A dynamically frustrated allosteric checkpoint consistent with conformational proofreading in CRISPR-Cas9.Nucleic acids research · 2026Article
- From sites to structure to serology: a roadmap for structure-aware molecular evolution of antigenically evolving viruses.Journal of virology · 2026Review
- AbTune: layer-wise selective fine-tuning of protein language models for antibodies.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Protein language models (PLMs) have recently emerged as a promising approach for next-generation variant-effect prediction (VEP). Most high-performing VEP methods currently utilize PLMs combined with additional information, such as homology, protein structure and population genetics data to improve prediction accuracy. This performance gain, however, comes with added complexity or limited applicability compared to pure PLMs trained only on raw, unaligned sequences, such as evolutionary scale modeling (ESM). Here we challenge the prevailing view that sequence-only PLMs are intrinsically limited and present an efficient co-distillation approach to adapt them for high-accuracy VEP without requiring additional information beyond evolutionary signals captured during pretraining. We allow individual PLMs to self-improve by distilling the most confident predictions from multiple models of the same family and demonstrate that co-distillation of ESM models suffices to achieve state-of-the-art performance across multiple VEP benchmarks. We further show that this performance increase enables accurate quantification of the severity of variant effects on continuous clinical phenotypes in biobank data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.